TCL Archive Anticancer Vaccine Trials Due In Three-Four Years; Virus Research Opportunities Described July 25, 1975
TCL Archive EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure. March 2, 2007
TCL Archive NCI Will Get $1.3 Billion, But Only If Congress Fends Off GRH Cuts, Reprogramming For Drug War October 3, 1986
